FDA says knockoff versions of Lilly obesity drug must come off the market
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.
Fire crews: 5 injured after lithium powder fire breaks out in Orlando business
Five people were injured Thursday morning after lithium powder caused a fire to break out in an Orlando business, fire ...
FDA keeps Mounjaro off shortage list after reevaluation
The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a ...
Bloomberg L.P.6h
Lilly Weight-Loss Drug Shortage in US Has Ended, FDA Says
Eli Lilly & Co.’s weight-loss and diabetes drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...
Zepbound, Mounjaro shortages are resolved, FDA confirms
The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a ...
Carpenter Technology Corp.: Robust Performance Into 2025 Despite Overvaluation - Hold
Carpenter Technology has shown resilient market performance, especially in aerospace/defense. Read why I have rated CRS stock ...